Cefdinir

Product NDC: 33261-905
11-digit product format: 332610905
Labeler code: 33261
Product ID: 33261-905_bb942e65-f5fb-4d99-801e-79c6b680e217
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cefdinir
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Labeler: Aidarex Pharmaceuticals LLC
Application: ANDA065259
Marketing category: ANDA
Marketing start: 2007-05-01
Marketing end: 0000-00-00
Substance: CEFDINIR
Active strength: 250 mg/5mL
Pharmacologic classes: Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	33261-905		I	Inactivated by FDA		2026-08-03
excluded package	package	33261-905	33261-905-00	I	Inactivated by FDA		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 42 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	33261-905-00	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	33261-905-00	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	33261-905-00	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	33261-905-00	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	33261-905-00	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	33261-905-00	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	33261-905-00	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	33261-905-00	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	33261-905-00	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	33261-905-00	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	33261-905-00	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	33261-905-00	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	33261-905-00	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	33261-905-00	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	33261-905-00	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	33261-905-00	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	33261-905-00	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	33261-905-00	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	33261-905-00	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	33261-905-00	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	33261-905-00	`9bebd1f3094a…`	`5416666fcb17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065259-001	CEFDINIR	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2006-05-31
A065259-002	CEFDINIR	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-05-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A065259-001	AB
A065259-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065259-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2006-05-31	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065259-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2007-05-07	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A065259-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065259-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065259-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065259-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065259-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065259-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065259-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065259-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065259-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065259-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065259-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065259-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065259-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065259-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065259-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065259-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065259-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065259-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065259-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065259-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065259-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065259-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065259-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065259-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065259-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065259-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065259-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065259-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065259-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065259-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065259-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065259-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065259-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065259-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065259-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065259-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065259-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065259-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A065259-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A065259-002	AB	1	`782e0a99824c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d3e72f63-2c41-955f-f4ce-e90c6403e67c	Product name	2	20210729
e8e66e64-d220-99cb-44eb-0f32dc8cbda1	Product name	2	20210729
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
33261-905-00	2020-01-31	C162847	48780-1	9d75b9d0-2ed8-f424-e053-dadaa90a57ce	Cefdinir for Oral Suspension USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
33261-905-00	Cefdinir	100 mL in 1 BOTTLE	POWDER, FOR SUSPENSION	100		2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEFDINIR	ACTIVE INGREDIENT	CI0FAO63WC	CEFDINIR POWDER, FOR SUSPENSION [AIDAREX PHARMACEUTICALS LLC]	2
CEFDINIR	ACTIVE MOIETY	CI0FAO63WC	CEFDINIR POWDER, FOR SUSPENSION [AIDAREX PHARMACEUTICALS LLC]	2
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	CEFDINIR POWDER, FOR SUSPENSION [AIDAREX PHARMACEUTICALS LLC]	2
GUAR GUM	INACTIVE INGREDIENT	E89I1637KE	CEFDINIR POWDER, FOR SUSPENSION [AIDAREX PHARMACEUTICALS LLC]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEFDINIR POWDER, FOR SUSPENSION [AIDAREX PHARMACEUTICALS LLC]	2
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	CEFDINIR POWDER, FOR SUSPENSION [AIDAREX PHARMACEUTICALS LLC]	2
SODIUM CITRATE	INACTIVE INGREDIENT	1Q73Q2JULR	CEFDINIR POWDER, FOR SUSPENSION [AIDAREX PHARMACEUTICALS LLC]	2
STRAWBERRY	INACTIVE INGREDIENT	4J2TY8Y81V	CEFDINIR POWDER, FOR SUSPENSION [AIDAREX PHARMACEUTICALS LLC]	2
SUCROSE	INACTIVE INGREDIENT	C151H8M554	CEFDINIR POWDER, FOR SUSPENSION [AIDAREX PHARMACEUTICALS LLC]	2
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	CEFDINIR POWDER, FOR SUSPENSION [AIDAREX PHARMACEUTICALS LLC]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
33261-905	CEFDINIR POWDER, FOR SUSPENSION [AIDAREX PHARMACEUTICALS LLC]	2	Legacy NDC, 1 package rows	20120914_8640931e-317a-42b4-806a-146f00ddf2a6.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cefdinir	CEFDINIR	Preferred Pharmaceuticals Inc.	3714d558-cbaa-42e8-831b-ffbbc951ebf2	2026-04-21	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259
Cefdinir	CEFDINIR	A-S Medication Solutions	17b4e82f-4169-4ab9-bd4a-79781a71e160	2025-12-19	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259
Cefdinir	CEFDINIR	Lupin Pharmaceuticals, Inc.	7490df67-56c0-4a1c-8533-2107f3e8aea5	2025-09-23	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259
Cefdinir	CEFDINIR	Asclemed USA, Inc.	e90660c8-2714-4592-aeaa-bc9ceb26057c	2025-04-19	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259
Cefdinir	CEFDINIR	NuCare Pharmaceuticals, Inc.	2fb43fbe-2c4b-1df9-e063-6394a90a9913	2025-03-06	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259
Cefdinir	CEFDINIR	NuCare Pharmaceuticals,Inc.	fbd76f8c-e6b8-52f4-e053-6394a90aa7ab	2025-02-04	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259
CEFDINIR	CEFDINIR	DIRECT RX	982d0f53-20bc-1cb4-e053-2995a90ad33c	2025-01-22	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259
Cefdinir	CEFDINIR	NuCare Pharmaceuticals,Inc.	1bbd75ea-5a50-eb00-e063-6394a90a1cec	2024-06-25	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259
Cefdinir	CEFDINIR	A-S Medication Solutions	37b5d000-db9e-4b6e-8208-6361e98fb55d	2023-11-01	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259
Cefdinir	CEFDINIR	Proficient Rx LP	444cd2c4-836d-40d5-a307-d719fe83e763	2022-05-02	Warnings	Exact identifier application applno (ANDA): 065259 application number: ANDA065259

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
CI0FAO63WC	CEFDINIR	91832-40-5	CEFDINIR

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
476576	cefdinir 250 MG in 5 mL Oral Suspension	PSN	8640931e-317a-42b4-806a-146f00ddf2a6	2
476576	cefdinir 50 MG/ML Oral Suspension	SCD	8640931e-317a-42b4-806a-146f00ddf2a6	2
476576	cefdinir 250 MG per 5 ML Oral Suspension	SY	8640931e-317a-42b4-806a-146f00ddf2a6	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
33261-905-00	33261090500	100 mL in 1 BOTTLE	100 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cefdinir for Oral Suspension USP	Aidarex Pharmaceuticals LLC	2012-09-12	HUMAN PRESCRIPTION DRUG LABEL	2